Athena Investment Management
13F filer · CIK 1921093 · Orinda, CA
Summary
Athena Investment Management reported $168.67M across 132 positions in its 13F for 2026 Q2, filed Aug 6, 2026. The largest holdings are SCHX (17.1%), SCHA (5.3%), SCHF (4.8%). Versus 2026 Q1, leaving options aside, it opened 4 new positions, added to 5, trimmed 107 and sold out of 25.
Reported value$168.67M
Positions132
Report period2026 Q2
FiledAug 6, 2026
New positions4
Added5
Trimmed107
Sold out25
Top 25 holdings
By reported value, options listed separately · change vs 2026 Q1
Weight 17.1%Value $28.84MPrice $30.09Shares 980K -25.02%Since Jun 30 +2.24%
Weight 5.3%Value $9.01MPrice $32.77Shares 249K -16.44%Since Jun 30 -9.30%
Weight 4.8%Value $8.08MPrice $27.66Shares 292K -22.18%Since Jun 30 -0.14%
Weight 3.7%Value $6.21MPrice $334.98Shares 19K -21.81%Since Jun 30 +2.34%
Weight 2.6%Value $4.36MPrice $115.93Shares 31K -30.39%Since Jun 30 -16.97%
UnitedHealth Group Inc.No ticker matchTrim
Weight 2.5%Value $4.14MShares 9,963 -19.35%
Weight 2.4%Value $4.03MPrice $35.91Shares 119K -7.93%Since Jun 30 +6.12%
Weight 2.2%Value $3.67MPrice $508.96Shares 9,851 -29.25%Since Jun 30 +36.44%
Weight 1.8%Value $3.09MPrice $329.40Shares 11K -37.15%Since Jun 30 +13.83%
Weight 1.6%Value $2.65MPrice $352.28Shares 7,699 -15.05%Since Jun 30 +2.43%
Weight 1.5%Value $2.54MPrice $355.10Shares 6,731 -0.83%Since Jun 30 -6.00%
Weight 1.5%Value $2.50MPrice $279.01Shares 8,321 -13.58%Since Jun 30 -7.14%
Weight 1.5%Value $2.47MPrice $34.20Shares 67K -19.99%Since Jun 30 -7.24%
Weight 1.5%Value $2.45MPrice $186.94Shares 13K -15.27%Since Jun 30 -1.47%
Weight 1.4%Value $2.29MShares 6,137 -26.41%
Weight 1.4%Value $2.28MPrice $263.29Shares 9,063 -20.08%Since Jun 30 +4.63%
Weight 1.2%Value $2.02MPrice $89.94Shares 23K +510.20%Since Jun 30 +4.41%
Weight 1.2%Value $1.99MPrice $71.18Shares 28K +7.80%Since Jun 30 -0.10%
Weight 1.1%Value $1.90MPrice $288.04Shares 5,388 -9.93%Since Jun 30 -18.32%
Weight 1.1%Value $1.81MPrice $194.50Shares 9,520 +5.54%Since Jun 30 +2.09%
Weight 1.0%Value $1.74MPrice $113.66Shares 15K -14.64%Since Jun 30 -3.06%
Weight 1.0%Value $1.71MPrice $104.54Shares 16K -21.35%Since Jun 30 +0.63%
Weight 1.0%Value $1.64MPrice $128.69Shares 12K -15.78%Since Jun 30 -4.95%
Weight 1.0%Value $1.63MPrice $767.52Shares 2,180 -5.50%Since Jun 30 +2.49%
Weight 1.0%Value $1.62MPrice $512.01Shares 2,236 -26.16%Since Jun 30 -29.18%
| Stock | Weight | Value | Since Jun 30 | Shares change | Action |
|---|---|---|---|---|---|
| 17.1% | $28.84M | +2.24% | -25.02% | Trim | |
| 5.3% | $9.01M | -9.30% | -16.44% | Trim | |
| 4.8% | $8.08M | -0.14% | -22.18% | Trim | |
| 3.7% | $6.21M | +2.34% | -21.81% | Trim | |
| 2.6% | $4.36M | -16.97% | -30.39% | Trim | |
| UnitedHealth Group Inc.No ticker match | 2.5% | $4.14M | — | -19.35% | Trim |
| 2.4% | $4.03M | +6.12% | -7.93% | Trim | |
| 2.2% | $3.67M | +36.44% | -29.25% | Trim | |
| 1.8% | $3.09M | +13.83% | -37.15% | Trim | |
| 1.6% | $2.65M | +2.43% | -15.05% | Trim | |
| 1.5% | $2.54M | -6.00% | -0.83% | Trim | |
| 1.5% | $2.50M | -7.14% | -13.58% | Trim | |
| 1.5% | $2.47M | -7.24% | -19.99% | Trim | |
| 1.5% | $2.45M | -1.47% | -15.27% | Trim | |
| 1.4% | $2.29M | — | -26.41% | Trim | |
| 1.4% | $2.28M | +4.63% | -20.08% | Trim | |
| 1.2% | $2.02M | +4.41% | +510.20% | Add | |
| 1.2% | $1.99M | -0.10% | +7.80% | Add | |
| 1.1% | $1.90M | -18.32% | -9.93% | Trim | |
| 1.1% | $1.81M | +2.09% | +5.54% | Add | |
| 1.0% | $1.74M | -3.06% | -14.64% | Trim | |
| 1.0% | $1.71M | +0.63% | -21.35% | Trim | |
| 1.0% | $1.64M | -4.95% | -15.78% | Trim | |
| 1.0% | $1.63M | +2.49% | -5.50% | Trim | |
| 1.0% | $1.62M | -29.18% | -26.16% | Trim |
Weight is the share of the reported 13F value, including options at notional value. “Since Jun 30” compares the latest close with the quarter-end price implied by the filing (value ÷ shares).
Largest buys in 2026 Q2
ExxonMobil Holdings CorpNo ticker match≈ $1.36MNew
Largest sells in 2026 Q2
Source: SEC Form 13F, values as reported by the filer. Filings lag up to 45 days after quarter end and cover only certain long positions. Research only, not investment advice.